Table 2.
Frequency of HPV test results and histologic diagnoses of patients in screening and diagnostic groups.
| HPV test result | Histologic diagnostic [n (%)] | Total | |||
|---|---|---|---|---|---|
|
|
|||||
| Normal | ASCUS | LSILs | HSILs | ||
| HCII | |||||
| Screening group | |||||
| Positive | 59 (9.9) | 20 (10.6) | 18 (16.8) | 11 (78.6) | 108 (12.0) |
| Negative | 535 (90.1) | 168 (89.4) | 89 (83.2) | 3 (21.4) | 795 (88.0) |
| Total | 594 | 188 | 107 | 14 | 903 |
| Diagnostic group | |||||
| Positive | 65 (30.7) | 38 (27.5) | 80 (41.9) | 196 (94.7) | 379 (50.7) |
| Negative | 147 (69.3) | 100 (72.5) | 111 (58.1) | 11 (5.3) | 369 (49.3) |
| Total | 212 | 138 | 191 | 207 | 748 |
| PCR | |||||
| Screening group | |||||
| Positive | 389 (65.5) | 135 (71.8) | 69 (64.5) | 11 (78.6) | 604 (66.9) |
| Negative | 205 (34.5) | 53 (28.2) | 38 (35.5) | 3 (21.4) | 299 (33.1) |
| Total | 594 | 188 | 107 | 14 | 903 |
| Diagnostic group | |||||
| Positive | 173 (81.6) | 109 (79.0) | 162 (84.8) | 195 (94.2) | 639 (85.4) |
| Negative | 39 (18.4) | 29 (21.0) | 29 (15.2) | 12 (5.8) | 109 (14.5) |
| Total | 212 | 138 | 191 | 207 | 748 |
Abbreviations: ASCUS, atypical squamous cell undetermined significance; LSILs, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; HCII, hybrid capture II; PCR, polymerase chain reaction.